Effects of Acute Exposure to Moderate Altitude on Vascular Function, Metabolism and Systemic Inflammation

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Stöwhas, Anne Christin ^a   Latshang, Tsogyal D ^a   Lo Cascio, Christian M ^a   Lautwein, Sina ^a   Stadelmann, Katrin ^b   Tesler, Noemi ^c   Ayers, Lisa ^d   Berneis, Kaspar ^a   Gerber, Philipp A ^a   Huber, Reto ^b,c   Achermann, Peter ^b   Bloch, Konrad E ^a,b   Kohler, Malcolm ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ALTITUDE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE METABOLISM; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYPOXEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID METABOLISM; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OXYGEN SATURATION; PARTICLE SIZE; SYMPATHETIC TONE;

ADULT; ALTITUDE; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; GLUCOSE; HUMANS; INFLAMMATION; LIPID METABOLISM; MALE; METABOLISM; OXYGEN;

EID: 84881006792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070081     Document Type: Article

References (34)

1. D'Este D, Mantovan R, Martino A, D'Este F, Artusi L, et al. (1991) The behavior of the arterial pressure at rest and under exertion in normotensive and hypertensive subjects exposed to acute hypoxia at a median altitude. GItal Cardiol 21: 643-649.
2. Greie S, Humpeler E, Gunga HC, Koralewski E, Klingler A, et al. (2006) Improvement of metabolic syndrome markers through altitude specific hiking vacations. J Endocrinol Invest 29: 497-504.
3. Lee WC, Chen JJ, Ho HY, Hou CW, Liang MP, et al. (2003) Short-term altitude mountain living improves glycemic control. High Alt Med Biol 4: 81-91.
4. Schobersberger W, Schmid P, Lechleitner M, Von Duvillard SP, Hoertnagl H, et al. (2003) Austrian moderate altitude study 2000 (AMAS 2000). The effects of moderate altitude (1700m) on cardiovascular and metabolic variables in patients with metabolic syndrome. Eur J Appl Physiol 88: 506-514.
5. Schobersberger W, Leichtfried V, Mueck-Weymann M, Humpeler E, (2010) Austrian moderate altitude studies (AMAS): benefits of exposure to moderate altitudes (1500-2500m). Sleep Breath 14: 201-207.
6. Temte JL, (1996) Elevation of serum cholesterol at high altitude and its relationship to hematocrit. Wilderness Environ Med 7: 216-224.
7. Kelly KR, Williamson DL, Fealy CE, Kriz DA, Krishnan RK, et al. (2010) Acute altitude-induced hypoxia suppresses plasma glucose and leptin in healthy humans. Metabolism 59: 200-205.
8. Licht CM, de Geus EJ, Penninx BW (2013) Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J Clin Endocrinol Metab jc.2012-3104 [pii];10.1210/jc.2012-3104 [doi].
9. Vats P, Ray K, Majumadar D, Amitabh, Joseph DA, et al. (2013) Changes in cardiovascular functions, lipid profile, and body composition at high altitude in two different ethnic groups. High Alt Med Biol 14: 45-52 10.1089/ham.2012.1071 [doi].
10. Clarenbach CF, Stoewhas AC, Van Gestel AJ, Latshang TD, Lo Cascio CM, et al. (2012) Comparison of photoplethysmographic and arterial tonometry-derived indices of arterial stiffness. Hypertens Res 35: 228-233.
11. Kohler M, Ayers L, Pepperell JCT, Packwood KL, Ferry B, et al. (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thoarx 64: 67-73.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
13. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, et al. (2001) Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 47: 418-425.
14. Berneis K, Rizzo M, Berthold HK, Spinas GA, Krone W, et al. (2010) Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial. Eur Heart J 31: 1633-1639.
15. Krauss RM, Burke DJ, (1982) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23: 97-104.
16. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827-838.
17. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765-774.
18. Bernardi L, Passino C, Spadacini G, Calciati A, Robergs R, et al. (1998) Cardiovascular autonomic modulation and activity of carotid baroreceptors at altitude. Clinical Science 95: 565-573.
19. Kanstrup IL, Poulsen TD, Hansen JM, Andersen LI, Bestle MH, et al. (1999) Blood pressure and plasma catecholamines in acute and prolonged hypoxia: effects of local hypothermia. J Appl Physiol 87: 2053-2058.
20. Vogel JA, Harris CW, (1967) Cardiopulmonary responses of resting man during early exposure to high altitude. J Appl Physiol 22: 1124-1128.
21. Wolfel EE, Selland MA, Mazzeo RS, Reeves JT, (1994) Systemic hypertension at 4,300m is related to sympathoadrenal activity. J Appl Physiol 76: 1643-1650.
22. Kop WJ, Vingerhoets A, Kruithof GJ, Gottdiener JS, (2003) Risk factors for myocardial infarction during vacation travel. Psychosom Med 65: 396-401.
23. Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, et al. (2003) Influence of altitude exposure on coronary flow reserve. Circulation 108: 1202-1207.
24. Rhodes HL, Chesterman K, Chan CW, Collins P, Kewley E, et al. (2011) Systemic blood pressure, arterial stiffness and pulse waveform analysis at altitude. J R Army Med Corps 157: 110-113.
25. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, et al. (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921.
26. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106: 3143-3421.
27. Rizzo M, Berneis K, (2006) Low-density lipoprotein size and cardiovascular prevention. Eur J Intern Med 17: 77-80.
28. Barnholt KE, Hoffman AR, Rock PB, Muza SR, Fulco CS, et al. (2006) Endocrine responses to acute and chronic high-altitude exposure (4300 meters): modulating effects of caloric restriction. Am J Physiol Endocrinol Metab 290: 1078-1088.
29. Ferezou J, Richalet JP, Coste T, Rathat C, (1988) Changes in plasma lipids and lipoprotein cholesterol during a high altitude mountaineering expedition (4800m). Eur J Appl Physiol Occup Physiol 57: 740-745.
30. Smith JD, Cianflone K, Martin J, Poirier P, Broderick TL, et al. (2011) Plasma adipokine and hormone changes in moutaineers on ascent to 5300 meters. Wilderness Environ Med 22: 107-114.
31. Dominguez Coello S, Cabrera De Leon A, Bosa Ojeda F, Perez Mendez LI, Diaz Gonzalez L, et al. (2000) High density lipoprotein cholesterol increases with living altitude. Int J Epidemiol 29: 65-70.
32. Bailey DM, Kleger GR, Holzgraefe M, Ballmer PE, Bartsch P, (2004) Pathophysiological significance of peroxidative stress, neuronal damage, and membrane premeability in acute mountain sickness. J Appl Physiol 96: 1459-1463.
33. Hartmann G, Tschop M, Fischer R, Bidlingmaier C, Riepl R, et al. (2000) High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12: 246-252.
34. Mazzeo RS, Donovan D, Fleshner M, Butterfield GE, Zamudio S, et al. (2001) Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade. J Appl Physiol 91: 2143-2149.